CAS: 2169919-21-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | SNDX-5613 REF: TM-T12943CAS: 2169919-21-3 | 98.7% | 72,00 €~1.049,00 € | Mar 04 Jun 24 |
 | SNDX-5613 REF: 3D-ULD91921CAS: 2169919-21-3 | Min. 95% | A consultar | Mar 16 Jul 24 |
SNDX-5613
CAS:2169919-21-3
SNDX-5613 is a potent and specific inhibitor of Menin-MLL(Ki of 0.149 nM and a cell …
Fórmula:
C32H47FN6O4S
Pureza:
98.7%
Forma y color:
Solid
Peso molecular:
630.82
Ref: TM-T12943
| 1mg | 72,00 € | |
| 2mg | 95,00 € | |
| 5mg | 157,00 € | |
| 10mg | 269,00 € | |
| 25mg | 531,00 € | |
| 50mg | 761,00 € | |
| 100mg | 1.049,00 € | |
| 1ml*10 (DMSO) | 214,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Junio de 2024
SNDX-5613
CAS:2169919-21-3
Revumenib, also known as SNDX-5613, is a potent and selective inhibitor of the interaction between …
Fórmula:
C32H47FN6O4S
Pureza:
Min. 95%
Peso molecular:
630.8 g/mol
Ref: 3D-ULD91921
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 16 de Julio de 2024
